Thioxanthene derivatives for the treatment of infectious diseases

Details for Australian Patent Application No. 2010240999 (hide)

Owner BKG Pharma ApS

Inventors Giwercman, Birgit Kjaeldgaard

Agent FB Rice

Pub. Number AU-B-2010240999

PCT Pub. Number WO2010/122012

Priority 09158229.6 20.04.09 EP; 61/202,918 20.04.09 US

Filing date 20 April 2010

Wipo publication date 28 October 2010

Acceptance publication date 20 September 2012

International Classifications

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/5415 - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/122012 Priority application(s): WO2010/122012

20 September 2012 Application Accepted

  Published as AU-B-2010240999

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241006-Resorbable and biocompatible fibre glass compositions and their uses

2010240965-Thia-triaza-cyclopentazulenes as PI3-kinases inhibitors for the treatment of cancer